Clinical Trial Update: A 52-week Clinical Investigation of Princess® VOLUME PLUS Lidocaine in Subjects With Midface Volume Deficit

View source ↗

Summary

A 52-week clinical investigation evaluating the safety and efficacy of Princess VOLUME PLUS Lidocaine for midface volume deficit has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Midface Volume Deficit

Drugs mentioned

• Princess VOLUME PLUS Lidocaine (lidocaine-containing hyaluronic acid dermal filler)

Snippet

Sponsor: Croma-Pharma GmbH | Conditions: Midface Volume Deficit | Status: COMPLETED